Market›Health Care›Biotechnology›Biotechnology
MOLECULAR PARTNERS A ADR

MOLN

$4.46Jun 16, 2021 – Apr 24, 2026
Health CareBiotechnology$153M
MVM
+$0.0M

Every news event mapped to its market reaction — 47 events, 59 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-06-14+21.7%newsSeeking AlphaMolecular Partners reports positive preclinical data for first Switch-DARPin candidate
2024-10-22-15.4%M&ASeeking AlphaMolecular Partners stock climbs 6% on expanded radiopharmaceuticals deal
2024-08-26+11.2%newsSeeking AlphaMolecular Partners reports 1H results
2026-03-12-11.0%newsGlobeNewswireMolecular Partners Reports Highlights and Financial Results for Full Year 2025
2026-03-12-11.0%earningsSeeking AlphaMolecular Partners GAAP EPS of -CHF1.65 beats by CHF0.32
2024-01-05+10.7%newsSeeking AlphaMolecular Partners, Orano to collaborate on RDT therapies for cancer
2025-05-13-9.3%analystSeeking AlphaMolecular Partners: Sluggish Progress But Worth Monitoring (Rating Downgrade)
2024-03-15+8.7%earningsSeeking AlphaMolecular Partners AG (MOLN) Q4 2023 Earnings Call Transcript
2025-06-10-7.4%newsSeeking AlphaMolecular Partners to cut jobs, cash reach now anticipated to extend into 2028
2024-03-14+7.4%earningsSeeking AlphaMolecular Partners GAAP EPS of -$1.89 beats by $0.14, revenue of $7.0M beats by $1.93M
2025-01-13+7.3%newsSeeking AlphaMolecular Partners & Orano Med join hands for alpha radio-therapies for cancer
2024-10-25+7.0%newsSeeking AlphaMolecular Partners prices $20M offering
2025-01-15+6.8%newsSeeking AlphaMolecular Partners: Leveraging Its Biologics Platform Into Early Clinical Programs
2023-03-10+6.5%earningsSeeking AlphaMolecular Partners AG (MOLN) Q4 2022 Earnings Call Transcript
2023-03-10+6.5%earningsSeeking AlphaMolecular Partners AG 2022 Q4 - Results - Earnings Call Presentation
2022-04-29-6.4%legalGlobeNewswireMolecular Partners ADRs Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Molecular Partners AG - GlobeNewswire
2026-02-02+6.4%newsMarketBeatMolecular Partners Highlights Favorable MP0712 DLL3 Radiotherapeutic Imaging, U.S. Phase I/II Ready
2026-02-02+6.4%newsSeeking AlphaMolecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript
2023-04-20+6.1%newsSeeking AlphaMolecular Partners: Sellers Have Disappeared, Enterprise Value Below Zero
2026-03-17+5.9%newsGlobeNewswireMolecular Partners to Hold Three Poster Presentations at AACR 2026
2026-03-17+5.9%earningsSeeking AlphaMolecular Partners AG 2025 Q4 - Results - Earnings Call Presentation
2026-03-23-5.8%newsGlobeNewswireMolecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors
2023-03-09-5.6%earningsSeeking AlphaMolecular Partners GAAP EPS of $3.54 misses by $0.52, revenue of $189.6M misses by $5.3M
2026-04-19+5.1%newsGlobeNewswireMolecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712
2026-02-04+4.1%newsSeeking AlphaMolecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 - Slideshow
2025-11-13+3.9%newsSeeking AlphaMolecular Partners AG (MOLN) Discusses First Human Imaging Data and Clinical Plans for MP0712 Radiotherapy Program Transcript
2025-03-06+3.5%earningsSeeking AlphaMolecular Partners GAAP EPS of -CHF 1.59, revenue of CHF 5M
2025-03-06+3.5%earningsSeeking AlphaMolecular Partners GAAP EPS of -CHF1.59, revenue of CHF5.0M
2025-03-07-3.2%earningsSeeking AlphaMolecular Partners AG (MOLN) Q4 2024 Earnings Call Transcript
2024-04-02-3.1%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2024-01-08+3.0%newsSeeking AlphaMolecular Partners says data from projected therapeutically active doses of MP0533 from Phase 1/2a trial to be presented in H1
2026-03-19+2.8%newsGlobeNewswireMolecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes
2026-04-14-2.3%newsGlobeNewswireMolecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting
2024-01-11+2.1%earningsSeeking AlphaMolecular Partners AG 2024 Q2 - Results - Earnings Call Presentation
2024-08-07+2.1%newsSeeking AlphaMolecular Partners: A Speculative Bet On Innovative DARPin Technology
2026-04-21-1.9%earningsMarketBeatMolecular Partners (NASDAQ:MOLN) Stock Price Up 5% - Still a Buy? - MarketBeat
2025-05-16+1.9%earningsSeeking AlphaMolecular Partners reports Q1 results
2026-01-19-1.5%newsSeeking AlphaMolecular Partners AG (MOLN) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
2023-08-25+0.5%earningsSeeking AlphaMolecular Partners AG (MOLN) Q2 2023 Earnings Call Transcript
2026-04-22+0.5%earningsMarketBeatMolecular Partners (NASDAQ:MOLN) Given "Buy" Rating at HC Wainwright - MarketBeat
2026-04-22+0.5%analystInvesting.com South AfricaH.C. Wainwright reiterates Molecular Partners stock rating at buy By Investing.com - Investing.com South Africa
2026-02-26+0.5%newsGlobeNewswireMolecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results
2026-02-26+0.5%expansionGlobeNewswireMolecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics
2026-01-15-0.4%newsSeeking AlphaMolecular Partners AG (MOLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2021-06-17-0.3%earningsMarketBeatMolecular Partners (MOLN) Stock Price, News & Analysis - MarketBeat
2026-03-04-0.2%earningsTradingViewWill Petrobras Pull Off Q4 Earnings Beat on Strong Production? - TradingView
2026-04-06+0.0%newsSimply Wall St.3 European Penny Stocks With Market Caps Under €600M
tickerdossier.comtickerdossier.substack.com